At WebSummit 2024, I had the pleasure of visiting the booth of Apolo AI, a pioneering HealthTech company based in Spain. While at their booth, I witnessed a demonstration of CARDIA’s 3D heart reconstruction. I was amazed by the precision and clarity of their technology. Seeing how they bring the heart to life in three dimensions was a powerful reminder of how far innovation can take us in transforming healthcare.

Their innovative solution, CARDIA, is truly revolutionizing the way we approach cardiovascular diagnostics by harnessing the power of AI to improve speed, accuracy, and patient outcomes.
🩺 What is CARDIA?


CARDIA is the software that automates 3D heart reconstruction from affordable 2D echocardiograms, providing precise clinical metrics and diagnostic support. This groundbreaking technology enables:
- 3D reconstruction of the heart, ensuring anatomical consistency.
- Advanced analysis, including segmentation, volumetric measurements, and strain analysis.
- Fast and affordable diagnosis, reducing the process from 3 months to 10 minutes while significantly cutting costs.
By leveraging AI-trained on over 1.5 million medical images, CARDIA offers cardiologists a powerful tool for early detection and effective treatment of cardiovascular diseases, which remain the leading cause of death worldwide.
💡 Why Apolo AI Matters
Traditional methods for diagnosing heart conditions are time-consuming, costly, and prone to variability. CARDIA simplifies this process, making it faster, more accessible, and more reliable. Their SaaS-based solution seamlessly integrates with existing healthcare platforms, ensuring broad adoption without the need for costly upgrades.
🚀 The Road Ahead
Led by a visionary team, including Daniel Ferrer Cid (Co-Founder), Arturo Wagener (COO), and Carla Burgos (Business Development), Apolo AI is on track to expand its capabilities beyond cardiology into areas like dermatology, hepatology, and nephrology. Their focus on scalability and adaptability makes them a company to watch in the MedTech space.
At YOUR R&D, we share Apolo AI’s passion for innovation that improves lives. It was inspiring to see their progress firsthand, and I look forward to seeing how they continue to revolutionize cardiology.
Learn more about their work at apoloai.com or connect with their team on LinkedIn.
#HealthTech #CardiologyInnovation #AIinHealthcare #WebSummit2024 #YOURRND #ApoloAI